CFTR modulators and biologics have had a significant impact on the treatment of cystic fibrosis and severe asthma in recent years. Despite all the benefits that these active substances bring, some patients can also experience significant side effects. Some extrapulmonary consequences still receive too little attention in practice.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Cardiometabolic research
The liver-heart axis in the pathogenesis of cardiometabolic diseases
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Heart rhythm
From harmonious symphony to age-related dissonance
- Precision therapy
Targeted MET inhibition after progression with osimertinib
- Chronic cough
Differential diagnostic detective work and trial therapies
- Cancer in Europe: facts and analysis
New Health Policy Report published
- Glomerulonephritis: IgA nephropathy